CEPESEDAN DIN 02335441
Health Canada record
| Active ingredient(s) | DETOMIDINE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 23-Nov-2010 |
| Current status date | 23-Nov-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Modern Veterinary Therapeutics Inc — licence 3-002686, currently licensed, last inspection rating I (2026-07-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DETOMIDINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02485303 | DOMIDINE | EUROVET ANIMAL HEALTH B.V. | Solution | DETOMIDINE HYDROCHLORIDE 10 MG | Marketed |
| 01927027 | DORMOSEDAN | ORION CORPORATION | Solution | DETOMIDINE HYDROCHLORIDE 10 MG | Marketed |
| 02355957 | DORMOSEDAN GEL | ORION CORPORATION | Gel | DETOMIDINE HYDROCHLORIDE 7.6 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22259 | 2019-06-10 | Supplement to an Abbreviated New Drug Submission (SANDS) | ADDITION OF A MANUFACTURING SITE |
| 10661 | 2009-10-14 | Abbreviated New Drug Submission (ANDS) |
International API supply for DETOMIDINE HYDROCHLORIDE
16 active FDA Drug Master Files.
Request a quote for CEPESEDAN